Liberty Hospital Receives Bridging the Pricing Transparency Gap Leadership Award

Posted on by

Liberty Hospital Receives Bridging the Pricing Transparency Gap Leadership Award

We are exceptionally proud to honor Liberty Hospital with this award, said Roger Shaul, President at PMMC. This represents Liberty Hospitals leadership, innovation, and proactive approach to addressing price transparency in todays increasingly consumer-driven healthcare world.

Liberty Hospital is a state-of-the-art 250 bed hospital located just north of Kansas City, MO. The hospital utilizes PMMC Contract PRO to manage their third party payer contracts and monitor underpayments. In April 2014, the organization engaged PMMC to conduct a strategic pricing engagement to responsibly set their prices. The project leveraged the expected contractual calculations in PMMC Contract PRO, to ensure that their prices are in line with the market.

Liberty Hospital is committed to providing our patients with exceptional care and ensuring that our prices are in line with the market, said CFO Dan Williams. With the help of PMMC Contract PRO, we are also more efficient within the revenue cycle.

The Bridging the Pricing Transparency Gap award represents best-in-class hospitals and healthcare systems who have made it a priority to bridge the gap in their revenue cycle between retail prices and accurate reimbursement from third-party payers.

Over 100 other hospitals across the U.S. currently use PMMC Contract PRO to manage complex payer contracts to accurately monitor and simulate expected reimbursements. By accurately calculating the expected reimbursement at the time of billing and comparing it to the posted payments and adjustments, PMMC Contract PRO pinpoints payment variances quickly and efficiently.

About PMMC

PMMC provides industry leading revenue cycle solutions to more than 400 hospitals and 21,400 physician clients. By finding additional cash and creating more efficient workflow processes, PMMC helps healthcare providers improve their margins so they can focus on serving their patients. PMMC is a Microsoft-certified provider and earned the Healthcare Financial Management Association (HFMA) Peer Review designation for its Contract PRO and Estimator PRO products, meeting an objective third-party assessment of overall effectiveness, quality, and value. PMMC also ranks No. 5 on the Largest Revenue Cycle Management Firms list according to Modern Healthcare Magazine. For more information, contact Brad Josephson at (704) 944-3081 or visit http://www.PMMConline.com.

View original post here:

Liberty Hospital Receives Bridging the Pricing Transparency Gap Leadership Award

Governor, deputy to face-off in Riau election

Posted on by

The Riau Islands General Elections Commission (KPUD) is ready to hold a gubernatorial election, with the incumbent governor and deputy governor set to battle it out to leader the province.

Riau Islands KPUD head Said Sirajuddin said the election, held alongside other elections in seven regencies and mayoralties in October, was estimated to cost Rp 89 billion (S$9.36 million), less than the earlier estimate of Rp 121 billion.

"The budget is smaller because based on the new electoral law, an election is held in a single round, so it costs less," Sirajuddin told The Jakarta Post on Monday.

According to him, the election's stages had yet to be arranged because the General Elections Commission (KPU) was still discussing its regulations (PKPUs) with the House of Representatives' Commission II overseeing domestic governance on Tuesday.

"We're still waiting for the PKPU, which will be discussed by the KPU and Commission II tomorrow. We will arrange the election phases after the new PKPUs have been decided, including the election budget," said Sirajuddin.

According to him, based on the number of ballots obtained in the 2014 legislative election, only the Indonesian Democratic Party of Struggle (PDI-P) can nominate its candidates for governor and deputy governor for the 2015-2020 period without forming a coalition.

He added that the number of voters in the Riau Islands in the 2014 legislative election was 1.3 million, but his commission would recount the number of voters after the KPU issued the PKPU on simultaneous elections.

More than 50 per cent of eligible voters are found in Batam, while the rest are in Bintan, Karimun, Tanjungpinang, Natuna, Anambas and Lingga.

Meanwhile, Governor Muhammad Sani has declared he will team up with Batam Mayor Ahmad Dahlan to contest the election against Deputy Governor Soerya Respationo, as both vie for the gubernatorial seat for the 2015-2020 term.

Sani, a former bureaucrat and member of the Golkar Party Riau Islands supervisory board, announced Dahlan, who is also the Democratic Party's Batam Regional Executive Board chairman, as his running mate on Feb. 19.

View post:

Governor, deputy to face-off in Riau election

Broad, Bayer expand partnership to develop therapies for cardiovascular disease

Posted on by

The Broad Institute of MIT and Harvard have expanded their collaboration with Bayer HealthCare to include cardiovascular genomics and drug discovery. The goal of this new part of the alliance is to leverage insights from human genetics to help create new cardiovascular therapies.

"It is exciting to be expanding on our ongoing, successful partnership with Bayer in oncology," said Professor Eric Lander, President and Director of Broad Institute. "We are looking forward to a fruitful collaboration combining Bayer's expertise in the cardiovascular therapeutic area with Broad's deep knowledge of genomics and biology".

Cardiovascular genomics is an emerging field of cardiology that uses genomic information to characterize disease risk and identify new therapeutic targets for drug discovery. Cardiovascular disease is responsible for approximately one-third of all deaths worldwide each year. While a majority of cardiovascular disease can be associated with lifestyle factors such as tobacco consumption, diet, and level of physical activity, risk genes can influence the predisposition to cardiovascular disease, age of onset, and severity.

"We are excited to broaden our collaboration with the Broad Institute to the area of cardiovascular genomics to discover genes and mutational changes underlying cardiovascular disorders in order to develop new therapies and diagnostic options for these diseases," said Prof. Andreas Busch, Head of Global Drug Discovery and member of the Executive Committee of Bayer HealthCare. "We have been collaborating already for the last two years and have developed a very constructive partnership during this time."

As part of this strategic alliance, Broad Institute and Bayer HealthCare will collaborate on genetic discovery, target validation, and drug discovery activities. Governance for this alliance will be comprised of a joint steering committee and joint research committee that will oversee research progress and direction. Financial terms of the agreement were not disclosed.

###

About the Broad Institute of MIT and Harvard

The Eli and Edythe L. Broad Institute of MIT and Harvard was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to broadinstitute.org.

About Cardiology at Bayer

The rest is here:

Broad, Bayer expand partnership to develop therapies for cardiovascular disease